RecruitingNCT05863910
Real World Evidence on the Use of Medical Cannabis in Pediatrics
Real World Evidence on the Use of Medical Cannabis in Pediatrics: A Prospective Observational Study
Sponsor
University of Manitoba
Enrollment
500 participants
Start Date
Nov 20, 2023
Study Type
OBSERVATIONAL
Conditions
Summary
CAN-RWE is an observational study that is following 500 children who have authorizations for medical cannabis for two years from across Canada.
Eligibility
Min Age: 3 YearsMax Age: 17 Years
Inclusion Criteria4
- to 17 years
- have a medical document provided by a prescribing health care practitioner (i.e. physician, nurse practitioner, etc.) for the use of medical cannabis
- medical cannabis is authorized for pain, sleep, mood, behaviour, seizures, cancer or cancer-treatment related symptom management
- ability to respond to electronic questionnaires in English
Exclusion Criteria2
- individuals using cannabis for medical purposes without a medical cannabis authorization from a health care provider
- those only using cannabis recreationally
Interventions
DRUGMedical Cannabis
Any cannabis product that is available to participants through the Medical Cannabis Access Program is eligible to be included in this study.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT05863910
Related Trials
Phase I Study of SYS6043 in Patients With Advanced/Metastatic Solid Tumors
NCT074245475 locations
Molecular Prediction of Development, Progression or Complications of Kidney, Immune or Transplantation-related Diseases
NCT053181961 location
A Phase I/II Study of Zotiraciclib for Recurrent Malignant Gliomas With Isocitrate Dehydrogenase 1 or 2 (IDH1 or IDH2) Mutations
NCT055881411 location
Small Bowel Capsule Endoscopy in Lynch Syndrome
NCT074726861 location
Archival of Human Biological Samples in CU-Med Biobank
NCT047064811 location